Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Shubham Pant(The University of Texas MD Anderson Cancer Center), Eileen M. O’Reilly(Memorial Sloan Kettering Cancer Center), Vincent Chung(City of Hope), Colin D. Weekes(Massachusetts General Hospital), Alexis D. Leal(Mayo Clinic in Arizona), Peter C. DeMuth(Io Therapeutics (United States)), Thian Kheoh(Janssen (United States)), Craig Devoe(Northwell Health), Pashtoon Murtaza Kasi(Cornell University), Lochana M. Seenappa(Io Therapeutics (United States)), Muhammad Furqan(University of Iowa), Olca Baştürk(Memorial Sloan Kettering Cancer Center), Haley VanWyk, James Perry, Christopher M. Haqq(Unknown), Amy Tavares, Esther Welkowsky, Lisa K. McNeil, Zev A. Wainberg(University of California, Los Angeles)
Cited by 234
Related Papers
Colorectal cancer
|The Lancet|2019|5k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k